阿片类药物和免疫抑制:临床证据,作用机制和潜在的治疗方法
Jeffrey J Bettinger1, Bruce C Friedman2
1Pain Management, Saratoga Hospital Medical Group, Saratoga Springs, New York, USA.
Palliative medicine reports
|March 4, 2024
概括
阿片类药物可以抑制免疫系统,增加感染风险. 边缘作用的片受体 (MOR) 抗剂可以减轻这些免疫抑制作用,为服用阿片类药物治疗的患者提供潜在的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 片类药物已知会产生便秘等不良影响.
- 新出现的证据表明,阿片类药物也具有免疫抑制性质.
- 本综述研究了阿片类药物对免疫功能的影响.
研究的目的:
- 审查阿片类药物诱导的免疫抑制的临床前和临床证据.
- 探索与阿片类药物相关的免疫损害管理的潜在治疗考虑.
主要方法:
- 现有科学文献的叙述性审查.
- 在体外,动物和人类观察研究的分析.
- 对阿片类受体对抗剂的临床前数据的检查.
主要成果:
- 阿片类药物会影响炎症性细胞因子,免疫细胞活性和对病原体的敏感性.
- 人类研究表明阿片类药物使用者感染率增加,支持临床前发现.
- 阿片类药物免疫抑制对感染风险与其他因素的确切贡献尚不清楚.
结论:
- 吸食阿片类药物与免疫功能受损和感染风险增加有关.
- 边缘作用的片受体 (MOR) 抗剂显示出阻断免疫抑制作用的潜力.
- 需要对阿片类药物感染联系和MOR抗体治疗进行进一步的研究.
更多相关视频
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
Analgesia and Pain Management
618
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
618
Opioid Analgesics: Morphine and Other Natural Cogeners
249
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
249
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
Opioid Analgesics: Synthetic and Semisynthetic Opioids
295
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
295
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127


